Poxel Financial Statements From 2010 to 2024
| POXEL Stock | EUR 0.19 0.02 9.52% |
Check Poxel SA financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Poxel SA's main balance sheet or income statement drivers, such as , as well as many indicators such as . Poxel financial statements analysis is a perfect complement when working with Poxel SA Valuation or Volatility modules.
Poxel |
Poxel SA Company Return On Equity Analysis
Poxel SA's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Poxel SA Return On Equity | -3.23 |
Most of Poxel SA's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Poxel SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Poxel SA has a Return On Equity of -3.2337. This is 86.51% lower than that of the Biotechnology sector and 91.13% lower than that of the Health Care industry. The return on equity for all France stocks is notably higher than that of the company.
Poxel SA Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Poxel SA's current stock value. Our valuation model uses many indicators to compare Poxel SA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Poxel SA competition to find correlations between indicators driving Poxel SA's intrinsic value. More Info.Poxel SA is regarded third in return on equity category among its peers. It also is regarded third in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Poxel SA's earnings, one of the primary drivers of an investment's value.About Poxel SA Financial Statements
Poxel SA shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Poxel SA investors may analyze each financial statement separately, they are all interrelated. The changes in Poxel SA's assets and liabilities, for example, are also reflected in the revenues and expenses on on Poxel SA's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Poxel SA, a biopharmaceutical company, develops drugs for metabolic diseases with a primary focus on type II diabetes. The company was founded in 2009 and is headquartered in Lyon, France. Poxel SA operates under Pharmaceuticals And Biosciences classification in France and is traded on Paris Stock Exchange. It employs 33 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Poxel Stock Analysis
When running Poxel SA's price analysis, check to measure Poxel SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Poxel SA is operating at the current time. Most of Poxel SA's value examination focuses on studying past and present price action to predict the probability of Poxel SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Poxel SA's price. Additionally, you may evaluate how the addition of Poxel SA to your portfolios can decrease your overall portfolio volatility.